IL33 and allergic asthma: In the previous study, up-regulated IL-33 and ST2 expression in OVA-sensitized lungs are reduced through salidroside administration, reflecting that salidroside treats allergic asthma by repressing lung ILC2 activation via targeting the IL-33/ST2 axis [45].